Product Information
PITAVASTATIN 4 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1362 per EA under NDC 65862081490. Its NADAC has been published 131 times since Feb 21, 2024.
FDA first approved this application on Dec 20, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862081490
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206015FDA Approved
12/20/2016
TE Code
AB
On Market Since
11/2/2023
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 4 MG TABLET has been published 131 times since Feb 21, 2024, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1362 per EA |
|---|---|
| All-time high | $2.3451 (Mar 13, 2024) |
| All-time low | $1.1362 (Aug 19, 2026) |
| 52-week high | $1.5488 |
| 52-week low | $1.1362 |
| Median price | $1.5488 |
| Average price | $1.6171 |
| Largest weekly change | +24.9% (Aug 21, 2024) |
| Weeks tracked | 131 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PITAVASTATIN 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 4 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.1362 per EA (NDC 65862081490), effective Aug 19, 2026.
How has the price of PITAVASTATIN 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 4 MG TABLET has declined 51.6%. It has been tracked across 131 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 4 MG TABLET?
Since Feb 21, 2024, the NADAC for PITAVASTATIN 4 MG TABLET has ranged from a low of $1.1362 (Aug 19, 2026) to a high of $2.3451 (Mar 13, 2024), with a median of $1.5488 per EA.
Are there cheaper alternatives to PITAVASTATIN 4 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PITAVASTATIN 4 MG TABLET?
PITAVASTATIN 4 MG TABLET (NDC 65862081490) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.